Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Atovaquone

An antiparasitic naphthoquinone approved in the United States in 1992, used against Pneumocystis pneumonia; since 2000 it has also been available combined with proguanil to prevent and treat malaria. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Its structure mimics ubiquinone (coenzyme Q10), jamming the respiratory chain in the parasite's mitochondria; it is also related to lawsone, the pigment in henna.

AtovaquoneGo to the active ingredient →
AtovaquoneActive ingredientAtovaquoneCat. No. P-A212-001CAS 95233-18-4
Atovaquone-d4Isotopically labelledAtovaquone-d4Cat. No. P-A212-006CAS 2070015-14-2

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substanceAtovaquone CRSEDQM code Y0001572Family Atovaquone

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.